Hermes is a leading global provider of advanced medical imaging software solutions within the field of nuclear medicine.

Hermes was founded in 1976 in Stockholm and serves a diversified customer base compromising prestigious hospitals and hospital networks (300+ customers) in 40+ countries worldwide. The company’s software platform Hermia is vendor-neutral and encompasses state-of-the art functionalities to visualise, analyse and quantify molecular imaging data. The software enables fast and accurate diagnosis of patients leveraging artificial intelligence.

Segulah V invested in Hermes in April 2016 to accelerate Hermes continued global expansion.